Tracing macroplastics redistribution and fragmentation by tillage translocation.

Soil is polluted with plastic waste from macro to submicron level. Our understanding of macroplastics (> 5 mm) occurrence and behavior has remained comparatively elusive, mainly due to a lack of a tracing mechanism. This study set up a methodology to trace macroplastic displacement, which combined magnetic iron oxide-tagged soil and macroplastic pieces tagged by an adhesive passive radiofrequency identification transponder.

Pharmatherapeutic Treatment of Osteoarthrosis-Does the Pill against Already Exist? A Narrative Review.

The aim of this narrative review is to summarize the current pharmacotherapeutic treatment options for osteoarthritis (OA). Is therapy still mainly symptomatic or does the pill against arthrosis already exist? Causal and non-causal, as well as future therapeutic approaches, are discussed. Various surgical and non-surgical treatment options are available that can help manage symptoms, slow down progression, and improve quality of life.

First evidence of widespread, severe soil erosion underneath centre-pivot irrigation systems.

Centre-pivot systems are widely used for irrigation in agriculture. However, excessive water application rates under low pressure centre-pivot systems can lead to soil erosion, which degrades soil structure and increases crop vulnerability to droughts. Although efforts have been deployed to measure soil erosion underneath individual centre pivots, a large-scale systematic assessment of extent and severity of soil erosion in centre-pivot irrigated fields is currently lacking.

Patient Specific Instruments and Patient Individual Implants-A Narrative Review.

Joint arthroplasties are one of the most frequently performed standard operations worldwide. Patient individual instruments and patient individual implants represent an innovation that must prove its usefulness in further studies. However, promising results are emerging.

Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients.

Glioblastoma is the most common and lethal primary brain malignancy that almost inevitably recurs as therapy-refractory cancer. While the success of immune checkpoint blockade (ICB) revealed the immense potential of immune-targeted therapies in several types of cancers outside the central nervous system, it failed to show objective responses in glioblastoma patients as of now. The ability of glioblastoma cells to drive multiple modes of T cell dysfunction while exhibiting low-quality neoepitopes, low-mutational load, and poor antigen priming limits anti-tumor immunity and efficacy of antigen-unspecific immunotherapies such as ICB.